STING1 and neoplasm: Four of twenty-five evaluable participants achieved stable disease for over 2 months in this heavily pre-treated population, and most exhibited activation of the STING pathway, as indicated by upregulation of IFN-stimulated genes in core tumour biopsies following SYNB1891 treatment [56].